natgillin/translations-raw huggingface dataset:
The broad spectrum antimicrobial activity of gamithromycin includes Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Actinobacillus pleuropneumoniae and Haemophilus parasuis, the bacterial pathogens most commonly associated with BRD and SRD.
Širok spektar antimikrobnog djelovanja gamitromicina uključuje Mannheimia haemolytica, Pasteurella multocida i Histophilus somni, Actinobacillus pleuropneumoniae i Haemophilus parasuis, , patogene bakterije najčešće povezane s BRD i SRD.
The Broadline-treated cats were compared with cats treated with a spot-on medicine containing fipronil and (S)-methoprene.
Mačke tretirane VMP-om Broadline uspoređene su s mačkama tretiranima spot-on VMP-om koji sadrži fipronil i (S)-metopren.
The bronchodilatory effects with Incruse compared with placebo were evident after the first day of treatment in both studies and were maintained over the 12-week and 24-week treatment periods.
Bronhodilatacijski učinci kod primjene lijeka Incruse u odnosu na placebo u oba su ispitivanja bili primjetni već nakon prvoga dana liječenja, a održali su se tijekom čitavog 12-tjednog i 24-tjednog razdoblja liječenja.
The buccal tablets are flat-faced, round bevelled-edge tablet, embossed one side with a “C” and on the other side with “1” for Effentora 100 micrograms, with “2” for Effentora 200 micrograms, with “4” for Effentora 400 micrograms, with “6” for Effentora 600 micrograms, with “8” for Effentora
Bukalne tablete su plosnate, okrugle ukošenih rubova, s oznakom „C“ s jedne strane, a s druge strane s oznakom „1“ za Effentoru 100 mg, „2“ za Effentoru 200 mikrograma, „4“ za Effentoru
The C max (CV%) was 335.6 ng/mL (87%) in healthy volunteers (normal renal function); 801.2 ng/mL (56%) in severe renal function; 576.7 ng/mL (51%) in ESRD (dosing after dialysis) and 478.5 ng/mL (38%) in ESRD (dosing before dialysis).
Cmax (CV%) bila je 335,6 ng/ml (87%) u zdravih dobrovoljaca (normalna bubrežna funkcija); 801,2 ng/ml (56%) za teško oštećenje bubrežne funkcije; 576,7 ng/ml (51%) za ESRD (doziranje nakon dijalize) te 478,5 ng/ml (38%) za ESRD (doziranje prije dijalize).
The C1 esterase inhibitor protein is required to control the ‘complement’ and ‘contact’ systems, collections of proteins in the blood that fight against infection and cause inflammation.
Protein naziva inhibitor C1 esteraze potreban je za kontrolu „komplementnog” i ”kontaktnog” sustava, nakupina proteina u krvi koji se bore protiv infekcije i uzrokuju upalu.
The C1 inhibitor protein is required to control the ‘complement’ and ‘contact’ systems, collections of proteins in the blood that fight against infection and cause inflammation.
Protein inhibitor C1 potreban je za kontrolu „komplementnog” i „kontaktnog” sustava, nakupina proteina u krvi koji se bore protiv infekcija i uzrokuju upalu.
The calculated in vitro Ki values for all cytochrome (CYP) isoforms tested (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 and CYP4A9/11) indicated that sunitinib and its primary active metabolite are unlikely to induce metabolism, to any clinically relevant extent, of other actives substances that may be metabolised by these enzymes.
Izračun Ki vrijednosti in vitro za sve ispitane CYP izoforme (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 i CYP4A9/11) pokazao je kako nije vjerojatno da sunitinib i njegov primarni aktivni metabolit u klinički relevantnoj mjeri induciraju metabolizam drugih djelatnih tvari koje se mogu metabolizirati pomoću navedenih enzima.
the calculated volume of Busulfan Fresenius Kabi must be removed from the vial.
izračunati volumen lijeka Busulfan Fresenius Kabi mora se ukloniti iz bočice.
The calculated volume of Elaprase should be withdrawn from the appropriate number of vials.
Potrebno je izvući izračunati volumen Elaprasea iz odgovarajućeg broja bočica.
The calculated volume of olaratumab should be aseptically transferred into an empty intravenous infusion container.
Izračunati volumen olaratumaba potrebno je aseptičnom tehnikom prenijeti u prazan spremnik za intravensku infuziju.
the calculation of the dose and of the volume of infusion
izračun doze i volumena infuzije
the calculation of the infusion rate
izračun brzine infuzije
The calculation of the required dosage of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 1.1 % of normal activity.
Izračun potrebne doze faktora IX temelji se na empirijskom saznanju da 1 internacionalna jedinica (IU) faktora IX po kg tjelesne težine povisuje aktivnost faktora IX u plazmi 1,1% u odnosu na normalnu aktivnost.
The calculation of the required dose of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight is expected to increase the circulating level of factor IX by an average of 1.3 IU/dl (1.3 % of normal) in patients ≥ 12 years of age and by 1.0 IU/dl (1.0 % of normal) in patients < 12 years of age.
Izračun potrebne doze faktora IX temelji se na empirijskom saznanju da 1 internacionalna jedinica (IU) faktora IX po kg tjelesne težine očekivano povećava cirkulirajuću razinu faktora IX u plazmi za prosječno 1,3 IU/dl (1,3% normalne vrijednosti) u bolesnika u dobi ≥ 12 godina odnosno za 1,0 IU/dl (1,0% normalne vrijednosti) u bolesnika u dobi < 12 godina.
The calculation of the required dose of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight is expected to increase the circulating level of factor IX by an average of 1.3 IU/dl (1.3 % of normal) in patients ≥ 12 years of age and by 1.0 IU/dl (1.0 % of normal) in patients < 12 years of age.
Izračun potrebne doze faktora IX temelji se na empirijskom saznanju da 1 internacionalna jedinica (IU) faktora IX po kg tjelesne težine očekivano povećava cirkulirajuću razinu faktora IX u plazmi za prosječno 1,3 IU/dl (1,3% normalne vrijednosti) u bolesnika u dobi ≥ 12 godina, odnosno za 1,0 IU/dl (1,0% normalne vrijednosti) u bolesnika u dobi < 12 godina.
The calculation of the required dose of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 0.9 IU/dL (range from 0.5 to 1.4 IU/dL) or 0.9% of normal activity in patients 12 years and older (further information see section 5.2).
Izračun potrebne doze faktora IX temelji se na empirijskom nalazu da 1 internacionalna jedinica (IU) faktora IX po kg tjelesne težine povećava aktivnost faktora IX u plazmi za 0,9 IU/dl (raspon od 0,5 do 1,4 IU/dl) ili 0,9% normalne aktivnosti u bolesnika od 12 godina i starijih (za dodatne informacije vidjeti dio 5.2).
The calculation of the required dose of FVIII is based on the empirical finding that 1 IU FVIII per kg body weight raises the plasma FVIII activity by about 2 % of normal activity (in vivo recovery 2 IU/dl).
Izračun potrebne doze FVIII temelji se na empirijskom saznanju da 1 IU FVIII po kg tjelesne težine podiže aktivnost FVIII za približno 2% u odnosu na normalnu aktivnost (in vivo povrat 2 IU/dl).
The calculation will include your child's age and body weight, or body surface area.
Izračun će uključivati dob te tjelesnu težinu ili površinu djeteta.
The calendar printed on the blister containing the tablets should help you remembering when you last took a tablet of Thymanax.
Kalendar ispisan na blisteru koji sadrži tablete pomoći će Vam sjetiti se kada ste zadnji put uzeli Thymanax tabletu.
The calendar printed on the blister containing the tablets should help you remembering when you last took a tablet of Valdoxan.
Kalendar ispisan na blisteru koji sadrži tablete pomoći će Vam sjetiti se kada ste zadnji put uzeli Valdoxan tabletu.
The calibration time is set between the end of the synthesis time and the expiry time.
Vrijeme kalibracije je postavljeno između kraja sinteze i isteka roka valjanosti.
The calorie target is the maximum number of calories you will eat each day.
Ciljni broj kalorija označava maksimalan broj kalorija koji ćete na dan uzeti hranom.
The calorific value of sorbitol is 2.6 kcal/g.
Kalorijska vrijednost 2,6 kcal/g sorbitola.
The cancer cells need this amino acid to
Suprotno tome, normalne stanice mogu proizvoditi vlastiti asparagin i na njih lijek manje utječe.
The cap is imprinted with ‘890’.
Na kapici je otisnuta oznaka ’890’.
The cap is imprinted with ‘891’.
Na kapici je otisnuta oznaka ’891’.
The cap is imprinted with ‘892’.
Na kapici je otisnuta oznaka ’892’.
The cap is imprinted with ‘893’.
Na kapici je otisnuta oznaka ’893’.
The cap is imprinted with ‘929’.
Na kapici je otisnuta oznaka ’929’.
The cap is imprinted with ‘930’.
Na kapici je otisnuta oznaka ’930’.
The cap must be turned anticlockwise, unscrewed completely and removed (fig.
Zatvarač se mora okrenuti u smjeru suprotnom od kazaljke na satu, potpuno odvrnuti i ukloniti (sl.
The cap must be turned anticlockwise, unscrewed completely and removed (fig.
Čep se mora okrenuti u smjeru suprotnom od kazaljke na satu, potpuno ga odvrnuti i ukloniti (sl.
The cap of the vial should be removed and the stopper cleaned using an alcohol pad.
S bočice treba ukloniti kapicu i čep očistiti vatom natopljenom alkoholom.
The cap opens by pushing and turning.
Zatvarač se otvara pritiskanjem i okretanjem.
The cap should be rotated clockwise or counter clockwise one full turn.
Zatvarač treba okrenuti u smjeru kazaljke na satu ili obrnuto cijeli krug.
The cap should not be removed until you are ready to inject the medicine.
Ne smijete skinuti poklopac s brizgalice dok niste spremni ubrizgati lijek.
The capecitabine pivotal studies included females of childbearing potential and males only if they agreed to use an acceptable method of birth control to avoid pregnancy for the duration of the study and for a reasonable period thereafter.
U pivotalna ispitivanja kapecitabinom žene reproduktivne dobi i muškarci uključeni su samo ako su pristali koristiti neku prihvatljivu metodu kontrole začeća kako bi izbjegli trudnoću tijekom trajanja ispitivanja i u razumnom razdoblju nakon toga.
The CAPiTA study enrolled volunteers ≥ 65 years of age whose demographic and health characteristics may differ from those seeking vaccination.
Ispitivanje CAPiTA uključivalo je dobrovoljce u dobi ≥ 65 godina čija se demografija i zdravstvene karakterstike mogu razlikovati od onih koji traže cjepivo.
The CAPRIE study included 19,185 patients with atherothrombosis as manifested by recent myocardial infarction (<35 days), recent ischaemic stroke (between 7 days and 6 months) or established peripheral arterial disease (PAD).
Studija CAPRIE uključivala je 19 185 bolesnika s aterotrombozom koje se manifestirala kao nedavni infarkt miokarda (<35 dana), nedavni ishemijski moždani udar (između 7 dana i 6 mjeseci) ili utvrđena bolest perifernih arterija (BPA).
The CAPS trials with Ilaris included a total of 80 paediatric patients with an age range from 2 to 17 years (approximately half of them treated on an mg/kg basis).
Ispitivanja CAPS-a s Ilarisom uključivala su ukupno 80 pedijatrijskih bolesnika u dobi od 2 do 17 godina (otprilike polovica njih bila je liječena na temelju mg/kg).
The caps, alcohol pad, cotton ball or gauze pad, blister, and packaging may be put in your household waste.
Kapice, alkoholom natopljeni jastučić, vatu ili gazu, blister i pakiranje se mogu baciti u kućni otpad.
The capsule body is caramel opaque, printed with ‘250’ axially in black ink.
Tijelo kapsule je neprozirno, boje karamela, s oznakom ‘250’ uzdužno otisnutom crnom tintom.
The capsule cap is light blue opaque printed ‘M’ axially in black ink.
Kapica kapsule je neprozirna, svijetlo plava, s oznakom ‘M’ uzdužno otisnutom crnom tintom.
The capsule cap is light blue opaque printed ‘M’ axially in black ink.
Kapica kapsule je neprozirna, svijetloplava s oznakom ‘M’ uzdužno otisnutom crnom tintom.
The capsule contents will remain as fine granules in the milk or food.
Sadržaj kapsule ostaje u obliku finih granula u mlijeku ili hrani.
The capsule has a dark blue centre band, and a turquoise cap and body bearing the imprint of “alli”.
Kapsula ima tamnoplavi središnji prsten, i tirkiznu kapicu i tijelo s utisnutom oznakom „alli“.
The capsule has a turquoise cap and turquoise body bearing the imprint of “ROCHE XENICAL 120”.
Kapsula ima tirkiznu kapicu i tirkizno tijelo s natpisom " ROCHE XENICAL 120".
The capsule is an orange cap/white body hard capsule of 19.4 mm, printed with black ink imprinted with “10 mg” on body and “A733” on cap.
Tvrda kapsula veličine 19,4 mm sastoji se od narančaste kapice i bijelog tijela, s otisnutim oznakama crnom tintom „10 mg“ na tijelu i „A733“ na kapici.
The capsule is axially printed with MYLAN over PB100 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB100 crnom tintom na kapici i tijelu.
The capsule is axially printed with MYLAN over PB150 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB150 crnom tintom na kapici i tijelu.
The capsule is axially printed with MYLAN over PB200 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB200 crnom tintom na kapici i tijelu.
The capsule is axially printed with MYLAN over PB225 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB225 crnom tintom na kapici i tijelu.
The capsule is axially printed with MYLAN over PB25 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB25 crnom tintom na kapici i tijelu.
The capsule is axially printed with MYLAN over PB50 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB50 crnom tintom na kapici i tijelu.
The capsule is axially printed with MYLAN over PB75 in black ink on cap and body.
Na kapsuli je poprečno otisnuto MYLAN i PB75 crnom tintom na kapici i tijelu.
The capsule is now pierced and the contents can be inhaled.
Time probijate kapsulu, što omogućuje udisanje njenog sadržaja.
The capsule may be opened and the content suspended in a small amount of water or formula diet immediately before intake.
Kapsula se može otvoriti, a sadržaj raspršiti u maloj količini vode ili dijetalnog pripravka neposredno prije uzimanja.
The capsule may be stuck in the capsule chamber.
Kapsula se možda zaglavila u svojoj komori.
The capsule may be stuck in the capsule chamber.
Kapsula se može zaglaviti u svojoj komori.
The capsule may be taken with or without food
Kapsula se može uzeti s hranom ili bez nje.
The capsule or its contents should not be crushed, divided, dissolved, sucked or chewed as the enteric- coating of the microtablets prevents irritant effects on the gut.
Kapsulu ili njezin sadržaj ne smije se zdrobiti, razdijeliti, otopiti, sisati ili žvakati, jer acidorezistentna ovojnica mikrotableta sprječava iritirajući učinak na crijeva.
The capsule shell and printing ink contain gelatine, shellac, ammonium hydroxide, simethicone, propylene glycol, indigocarmin (E132) and titanium dioxide (E171).
Ovojnica kapsule i tinta za označavanje sadrže želatinu, šelak, amonijev hidroksid, simetikon, propilenglikol, indigokarmin (E132) i titanijev dioksid (E171).
The capsule shell and printing ink contain gelatine, shellac, ammonium hydroxide, simethicone, red iron oxide, black iron oxide, yellow iron oxide, propylene glycol, indigocarmin (E132) and titanium dioxide (E171).
Ovojnica kapsule i tinta za označavanje sadrže želatinu, šelak, amonijev hidroksid, simetikon, crveni željezov oksid, crni željezov oksid, žuti željezov oksid,propilenglikol, indigokarmin (E132) i titanijev dioksid (E171).
The capsule shell consists of gelatin, sorbitol special-glycerine blend (glycerin, sorbitol, sorbitol anhydrides (1,4-sorbitan), mannitol and water), titanium dioxide (E171) and printing ink (SDA 35A alcohol (ethanol & ethyl acetate), propylene glycol (E1520), iron oxide black (E172), polyvinyl acetate phthalate, purified water, isopropyl alcohol, macrogol 400, ammonium hydroxide 28%)
Ovojnica kapsule sastoji se od želatine, smjese sorbitola i glicerola (glicerol, sorbitol, sorbitol bezvodni (1,4-sorbitan), manitol i voda), titanijev dioksid (E171) i tinta za označavanje (SDA 35A alkohol (etanol & etilacetat), propilenglikol (E1520), željezov oksid crni (E172), poli(vinilacetat)ftalat, pročišćena voda, izopropilni alkohol, makrogol 400, amonijev hidroksid 28%).
The capsule shell consists of gelatine, iron oxide black, red and yellow (E172), indigocarmine (E132), titanium dioxide (E171), and the printing ink contains titanium dioxide (E171), shellac, soya lecithin, polydimethylsiloxane.
Ovojnica kapsule sastoji se od želatine, crnog, crvenog i žutog željezovog oksida (E172), indigotina (E132) i titanijevog dioksida (E171), a tinta za označavanje sadrži titanijev dioksid (E171), šelak, sojin lecitin i polidimetilsiloksan.
The capsule shell contains carrageenan, potassium chloride, titanium dioxide, indigo carmine, sunset yellow (E110) and hypromellose.
Ovojnica kapsule sadrži karagenan, kalijev klorid, titanijev dioksid, indigo karmin, sunset yellow (E 110) i hipromelozu.
The capsule shell contains carrageenan, potassium chloride, titanium dioxide, indigo carmine, sunset yellow (E110) and hypromellose.
Ovojnica kapsule sadrži karagenan, kalijev klorid, titanijev dioksid, indigo karmin, sunset yellow (E110) i hipromelozu.
The capsule shell contains gelatin and titanium dioxide (E171).
Ovojnica kapsule sadrži želatinu i titanijev dioksid (E171).
The capsule shell contains gelatin, red iron oxide, propylene glycol, purified water, ‘sorbitol special-glycerin blend’ (d-sorbitol, 1,4 sorbitan, mannitol and glycerin) and titanium dioxide.
Ovojnica kapsule sadrži želatinu, crveni željezov oksid, propilenglikol, pročišćenu vodu, mješavinu posebnog sorbitola s glicerinom (d-sorbitol, 1,4 sorbitan, manitol i glicerin) i titanijev dioksid.
The capsule shell contains: gelatin, titanium dioxide (E171), indigotine (E132) and yellow iron oxide (E172) and white and black ink.
Ovojnica kapsule sadrži: želatinu, titanijev dioksid (E171), indigotin (E132) i žuti željezov oksid (E172) i bijelu i crnu tintu.
The capsule shell contains: gelatin, titanium dioxide (E171), indigotine (E132), brilliant blue FCF (E133), and white ink.
Ovojnica kapsule sadrži: želatinu, titanijev dioksid (E171), indigotin (E132), briljantno plavi FCF (E133) i bijelu tintu.
The capsule shell contains: gelatin, titanium dioxide (E171), indigotine (E132), yellow iron oxide (E172) and white ink.
Ovojnica kapsule sadrži: želatinu, titanijev dioksid (E171), indigotin (E132) i žuti željezov oksid (E172) i bijelu tintu.
The capsule shell contains: gelatin, titanium dioxide (E171), indigotine (E132), yellow iron oxide (E172), erythrosin (E127) and white ink.
Ovojnica kapsule sadrži: želatinu, titanijev dioksid (E171), indigotin (E132), žuti željezov oksid (E172), eritrozin (E127) i bijelu tintu.
The capsule shell contains: gelatin, titanium dioxide (E171), shellac, propylene glycol, potassium hydroxide, black iron oxide (E172).
Ovojnica kapsule sadrži: želatinu, titanijev dioksid (E171), šelak, propilenglikol, kalijev hidroksid, crni željezov oksid (E172).
The capsule shell contains: gelatine, sodium laurilsulfate, titanium dioxide (E171) and silicon dioxide (E551).
Ovojnica kapsule sadrži: želatinu, natrijev laurilsulfat, titanijev dioksid (E171) i silicijev dioksid (E551).
The capsule shell contains: gelatine, sodium laurilsulfate, yellow iron oxide (E172) and silicon dioxide (E551).
Ovojnica kapsule sadrži: želatinu, natrijev laurilsulfat, žuti željezov oksid (E172) i silicijev dioksid (E551).
The capsule shell contains: gelatine, sodium laurilsulfate, yellow iron oxide (E172), titanium dioxide (E171) and silicon dioxide (E551).
Ovojnica kapsule sadrži: želatinu, natrijev laurilsulfat, žuti željezov oksid (E172), titanijev dioksid (E171) i silicijev dioksid (E551).
The capsule shell for the 20 mg capsule contains gelatin and titanium dioxide (E171).
Ovojnica kapsule od 20 mg sadrži želatinu i titanijev dioksid (E171).
The capsule shell for the 30 mg capsule contains gelatin, titanium dioxide (E171), red iron oxide (E172) and yellow iron oxide (E172).
Ovojnica kapsule od 30 mg sadrži želatinu, titanijev dioksid (E171), crveni željezov oksid (E172) i žuti željezov oksid (E172).
The capsule shell for the 40 mg capsule contains gelatin, titanium dioxide (E171) and yellow iron oxide (E172).
Ovojnica kapsule od 40 mg sadrži želatinu, titanijev dioksid (E171) i žuti željezov oksid (E172).
The capsule shell for the 5 mg and 10 mg capsules contains gelatin, titanium dioxide (E171) and red iron oxide (E172).
Ovojnica kapsule od 5 mg i 10 mg sadrži želatinu, titanijev dioksid (E171) i crveni željezov oksid (E172).
The capsule shell for the 60 mg capsule contains gelatin, titanium dioxide (E171) and yellow iron oxide (E172).
Ovojnica kapsule od 60 mg sadrži želatinu i titanijev dioksid (E171) i žuti željezov oksid (E172.
The capsule shell is composed of gelatin, titanium dioxide (E171), iron oxide yellow (E172) and iron oxide red (E172).
Ovojnica kapsule se sastoji od želatine, titanijevog dioksida (E171), žutog željezovog oksida (E172) i crvenog željezovog oksida (E172).
The capsule shell is made of gelatin, titanium dioxide (E171), erythrosine (E127), indigotin (E132).
Ovojnica kapsule se sastoji od želatine, titanijeva dioksida (E171), eritrozina (E127), indigotina (E132).
The capsule shell is made of gelatin, titanium dioxide (E171).
Ovojnica kapsule se sastoji od želatine, titanijeva dioksida (E171).
The capsule shell is made of gelatin, which is harmless to humans if swallowed or inhaled.
Ovojnica kapsule izrađena je od želatine, koja je bezopasna za ljude ako se proguta ili udahne.
The capsule should be swallowed whole with a glass of water during a meal.
Kapsule treba progutati cijele s čašom vode u tijeku obroka.
The capsule should be swallowed whole with a glass of water, to ensure delivery to the stomach.
Kapsula se treba progutati cijela s čašom vode kako bi se osiguralo njezino dospijevanje do želuca.
The capsules and oral solution can also be used for the treatment of dementia in adult patients with Parkinson’s disease.
Kapsule i oralna otopina također se mogu primjenjivati u liječenju demencije u odraslih bolesnika s Parkinsonovom bolešću.
The capsules and oral solution can also be used for the treatment of dementia in adult patients with Parkinson’s disease.
Kapsule i peroralna otopina mogu se primjenjivati i za liječenje demencije u odraslih bolesnika s Parkinsonovom bolešću.
The capsules and oral solution can also be used for the treatment of dementia in adult patients with Parkinson’s disease.
Kapsule i raspadljive tablete za usta također se mogu primjenjivati u liječenju demencije u odraslih bolesnika s Parkinsonovom bolešću.
The capsules are for inhalation use only and should not be swallowed.
Kapsule su isključivo namijenjene inhalaciji i ne smiju se gutati
The capsules are not to be swallowed.
Kapsule se ne smiju progutati.
The capsules are opaque pink and imprinted with ‘HYCAMTIN’ and ‘1 mg’.
Kapsule su neprozirno ružičaste boje s utisnutim «HYCAMTIN» i «1 mg».
The capsules are opaque white to yellowish white and imprinted with ‘HYCAMTIN’ and ‘0.25 mg’.
Kapsule su neprozirno bijele do žućkasto bijele boje s utisnutim «HYCAMTIN» i «0,25mg».
The capsules are printed with printing ink containing indigo carmine (E 132).
Oznaka na kapsuli otisnuta je tintom za označavanje koja sadrži boju indigo karmin (E132).
The capsules are printed with printing ink containing titanium dioxide (E 171), indigo carmine (E 132) and iron oxide (E 172).
Oznaka na kapsuli otisnuta je tintom za označavanje koja sadrži titanijev dioksid (E171), boju indigo karmin (E132) i željezov oksid (E172).
The capsules are provided in blisters and are available in packs containing 40 capsules or in multipacks containing 150 capsules (3 packs of 50).
Kapsule se isporučuju u blisterima i dostupne su u pakiranjima koja sadrže 40 kapsula ili u višestrukim pakiranjima koja sadrže 150 kapsula (3 pakiranja od 50).
The capsules are provided in packs.
Kapsule se isporučuju u pakiranjima.
The capsules are semi-translucent white and coded ‘CRIXIVAN 200 mg’ on them in blue.
Kapsule su poluprozirne bijele, s oznakom ‘CRIXIVAN ™ 200 mg’ plave boje.